Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Why P&G stock is down today as Procter & Gamble flags a $100 Potemkin mini-tender offer

Why P&G stock is down today as Procter & Gamble flags a $100 Potemkin mini-tender offer

New York, Jan 15, 2026, 11:56 ET — Regular session. Procter & Gamble shares dropped about 1.1% to $144.77 in late morning trade Thursday after the consumer goods giant urged investors to spurn an unsolicited “mini-tender” offer from Potemkin Limited. Potemkin proposed buying up to 50,000 shares at $100 each — roughly 31% below the $145.52 closing price on Dec.…
Applied Materials stock jumps today as TSMC lifts 2026 capex and Barclays upgrades AMAT

Applied Materials stock jumps today as TSMC lifts 2026 capex and Barclays upgrades AMAT

New York, Jan 15, 2026, 11:55 (ET) — Regular session underway. Applied Materials (AMAT.O) jumped 7.8% to $325.41 in late-morning trading Thursday, riding a wave of gains among chip equipment stocks following encouraging factory spending data. Lam Research gained 5.9%, KLA surged 9.0%, and U.S.-listed shares of Taiwan Semiconductor Manufacturing rose 6.9%. TSMC’s announcement to boost 2026 capital spending to…
Why Eli Lilly stock is down today: FDA pushes obesity pill decision to April 10

Why Eli Lilly stock is down today: FDA pushes obesity pill decision to April 10

New York, Jan 15, 2026, 12:06 (EST) — Regular session Eli Lilly and Company shares dropped 4.7% to $1,022.50 on Thursday after Reuters reported that internal documents revealed U.S. regulators delayed a decision on the drugmaker’s weight-loss pill until April 10. A Lilly spokesperson said approval could still come in the second quarter, aligning with current FDA guidance. Holly Fernandez…
ServiceNow stock slides again as Oppenheimer trims target and a security flaw stays in focus

ServiceNow stock slides again as Oppenheimer trims target and a security flaw stays in focus

New York, Jan 15, 2026, 11:32 ET — Regular session ServiceNow shares dropped Thursday following a price target cut from Oppenheimer, adding to the pressure on the workflow software company’s stock, which has struggled to hold steady this month. Shares slipped 1.4% to $132.68 by late morning, after dipping as low as $132.46 earlier. Oppenheimer’s Brian Schwartz cut his price…
IREN stock slips as broker trims forecasts but keeps $80 target

IREN stock slips as broker trims forecasts but keeps $80 target

New York, Jan 15, 2026, 11:52 AM EST — Regular session Shares of IREN Limited dipped Thursday following a downgrade in near-term earnings estimates by H.C. Wainwright. The brokerage, however, maintained its Buy rating and held firm on an $80 price target. (MarketBeat) The pullback is significant since IREN now acts as a high-beta stand-in for two volatile bets: bitcoin-related…
Mastercard stock slips after UK court backs cross-border fee cap plan

Mastercard stock slips after UK court backs cross-border fee cap plan

New York, January 15, 2026, 11:28 EST — Regular session Mastercard shares dropped 0.4% to $544.6 in late morning trading following a UK High Court decision siding with Britain’s payments regulator to cap some cross-border card fees. Visa gained 0.3%, while American Express inched up 0.1%. (Reuters) The decision shines a light on just how much wiggle room the major…
CoreWeave stock jumps as CEO swats down Nvidia “circular financing” talk

CoreWeave stock jumps as CEO swats down Nvidia “circular financing” talk

New York, Jan 15, 2026, 11:30 ET — Regular session Shares of CoreWeave (CRWV) jumped roughly 10% to $98.72 in late morning trading Thursday, fueled by a fresh wave of interest in AI-related stocks. The move came after CEO Michael Intrator addressed concerns about the company’s funding approach, pushing back on investor questions. This move is significant since CoreWeave now…
Salesforce stock drops as Wolfe sticks with $350 target, but AI anxiety still weighs on CRM

Salesforce stock drops as Wolfe sticks with $350 target, but AI anxiety still weighs on CRM

New York, January 15, 2026, 11:27 EST — Regular session Salesforce (CRM) shares were down 1.6% at $235.78 in late morning trade on Thursday, lagging a rise in major U.S. stock ETFs that track the Nasdaq and S&P 500. The pullback matters because investors have turned jumpy on big software names, pressing for signs that new “AI agents” — systems…
BitMine (BMNR) stock slides after $200 million Beast Industries deal as share-vote comes due

BitMine (BMNR) stock slides after $200 million Beast Industries deal as share-vote comes due

New York, Jan 15, 2026, 11:25 EST — Regular session Shares of BitMine Immersion Technologies dropped about 3% Thursday after the company announced a $200 million equity stake in Beast Industries, a creator-driven firm linked to YouTube star MrBeast. Chairman Thomas “Tom” Lee hailed MrBeast as “the leading content creator of our generation,” while Beast CEO Jeff Housenbold called the…
Goldman Sachs stock jumps on earnings beat and dividend hike as traders cash in on volatility

Goldman Sachs stock jumps on earnings beat and dividend hike as traders cash in on volatility

New York, January 15, 2026, 11:21 ET — Regular session Goldman Sachs shares rose nearly 4% on Thursday after the Wall Street bank topped fourth-quarter profit estimates and raised its dividend. The stock was up about 3.9% at $969.24, after closing at $932.67 on Wednesday. The results land as investors comb through bank earnings for signs that last year’s revival…
Johnson & Johnson stock slips as Tecvayli trial data lands ahead of earnings week

Johnson & Johnson stock slips as Tecvayli trial data lands ahead of earnings week

New York, Jan 15, 2026, 11:01 ET — Regular session Johnson & Johnson shares dipped Thursday following fresh late-stage data release for its Tecvayli cancer drug, with investors also bracing for next week’s earnings report. This update is crucial as Johnson & Johnson aims to expand the footprint of its newer drugs while shielding established products from pricing cuts and…
Rocket Lab stock slides on KeyBanc downgrade: what investors are watching for RKLB next

Rocket Lab stock slides on KeyBanc downgrade: what investors are watching for RKLB next

New York, Jan 15, 2026, 10:55 EST — Regular session Rocket Lab shares slipped Thursday following a downgrade from KeyBanc Capital Markets, halting a recent surge that had lifted the stock to new highs this month. The stock dropped roughly 4.3% to $87.90 in early trading. (MarketScreener) The stock closed Wednesday 6% higher at $91.80, fueling a sharp rally that…
1 235 236 237 238 239 901

Stock Market Today

  • Weak Dollar Spurs U.S. Stock Investors to Look at Overseas Markets
    January 31, 2026, 9:46 AM EST. The dollar's recent decline, described by President Trump as a 'yo-yo,' is causing shifts in equity investment strategy. A weaker dollar helps U.S. exporters by increasing overseas revenues but also makes American assets less attractive, driving funds out to international markets. Chris Zaccarelli, CIO at Northlight Asset Management, said the weakening dollar is a net negative for the U.S. stock market, prompting investors to favor export-oriented U.S. stocks, which have outperformed the S&P 500 this year. Meanwhile, international equities, especially in Europe, Japan, and Brazil, show stronger gains when adjusted for currency effects. This dynamic encourages portfolio rotations as investors seek better valuations and currency advantages outside the U.S.
Go toTop